R. Clive Landis, PhD, George Asimakopoulos, Mike Poullis, Dorian O

Slides:



Advertisements
Similar presentations
Excellent review article : Ley et al., Nature Immunology Reviews, 7:678, 2007 Video Acknowledgments to Dr. Tim Springer, Harvard University Homing of.
Advertisements

Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
CELL SIGNALING. THREE LEVELS OF CONTACT WITH ENVIRONMENT.
Acute inflammation 3 By Dr. S. Homathy. This is augmented by slowing of the blood flow and increased vascular permeability, fluid leaves the vessel causing.
 Cell surface molecules expressed (or disappeared) during different developmental and differential phases, activation or inactivation process of blood.
Chapter 8 Cell Adhesion Molecules (CAM)
Chapter 15 – Leukocyte Migration and Inflammation The IS relies upon the continual circulation of leukocytes through the body –For the Innate IR – a variety.
Chapter 13 Leukocyte Activation and Migration Dr. Capers
Topics Sensor systems Phagocytosis Inflammation Interferons Fever.
Interaction of Cells with Other Cells (5)
Adhesion Molecules Concept Naming Roles Classification.
Integrating Cells into Tissues
Inflammation lecture 2 Dr Heyam Awad FRCPath.
Inflammation The process of inflammation initiates from tissue injury or from foreign presence its initiation is triggered by the production of: a) chemokine.
Date of download: 6/3/2016 Copyright © American College of Chest Physicians. All rights reserved. Tissue Factor, Thrombin, and Cancer * Chest. 2003;124(3_suppl):58S-68S.
Date of download: 6/23/2016 From: Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates Ann Intern Med. 1993;119(12):
Protease Activated Receptors (PARs) Molecular Cell Biology, 2013 Paul Bauer Jens Berndtsson Eva Darai Adams et al. 2011, Pharmacology & Therapeutics Coughlin.
The Role of Cell Adhesion in Inflammation and Metastasis 赵燃 丁合
Inherited disorders of platelet function
T Lymphocyte Transmigration
Integrin signalling Vytášek 2010.
ANIMAL CELL CULTURE.
Transmembrane and GPCR Mohammed Mohammed Khan PhD Scholar- Department of Biochemistry King Abdul-Aziz University.
The antithrombotic effect of aprotinin: actions mediated via the protease-activated receptor 1  Michael Poullis, FRCSa, Richard Manning, BScb, Mike Laffan,
Volume 7, Issue 3, Pages (March 2005)
by Dachuan Zhang, Chunliang Xu, Deepa Manwani, and Paul S. Frenette
by William C. Aird Blood Volume 101(10): May 15, 2003
The State Diagram for Cell Adhesion Mediated by Two Receptors
Figure 1 Mechanism of thrombus formation during ST-segment
Road signs guiding leukocytes along the inflammation superhighway
Reopro removal during cardiopulmonary bypass using a hemoconcentrator
Cells into Tissues By Kevin Huyen.
Lymphoma dissemination: the other face of lymphocyte homing
Leukocyte-endothelial cell interactions: Molecular mechanisms and implications in gastrointestinal disease  Julián panés*, D.Neil Granger‡  Gastroenterology 
Thrombosis in flowing blood
Volume 55, Issue 6, Pages (December 2011)
Integrin signalling Vytášek 2009.
Chapter 14 Immune Response in Space and Time
Volume 9, Issue 2, Pages (January 2003)
Mechanisms of myocardial reperfusion injury
Monocyte Fc gamma receptor expression in patients undergoing coronary artery bypass grafting  Demetrios C Stefanou, FRCS, George Asimakopoulos, FRCS,
Volume 72, Issue 1, Pages 9-21 (October 2011)
Figure 3 Potential mechanisms of PAR activation by thrombin and aPC
Nat. Rev. Nephrol. doi: /nrneph
The Bone Marrow Is Akin to Skin: HCELL and the Biology of Hematopoietic Stem Cell Homing1  Robert Sackstein  Journal of Investigative Dermatology Symposium.
TGF-² Signaling Pathway in Lung Adenocarcinoma Invasion
Hans-Joachim Anders, Volker Vielhauer, Detlef Schlöndorff 
An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation  George Asimakopoulos, FRCSa, Richard Thompson, MRCPb, Sussan.
Jo-Ellen Murphy, Caroline Robert, Thomas S. Kupper 
Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies  C.P.R. Walker, D. Royston 
Jonathan R. S. Day, MRCS, Dorian O. Haskard, DM, Kenneth M
Defective neutrophil rolling and transmigration in acute uremia
Chemokines and leukocyte trafficking in rheumatoid arthritis
Figure 1 Mechanisms of platelet adhesion and aggregation
Volume 81, Issue 12, Pages (June 2012)
Anti-inflammatory Agents: Present and Future
The molecular biology of thrombotic microangiopathy
Protein kinase Cα: disease regulator and therapeutic target
Aprotinin inhibits proinflammatory activation of endothelial cells by thrombin through the protease-activated receptor 1  Jonathan R.S. Day, MRCS, Kenneth.
Mesenchymal Stem Cell Homing: The Devil Is in the Details
The molecular biology of thrombotic microangiopathy
Volume 71, Issue 12, Pages (June 2007)
Mechanisms of eosinophil-associated inflammation
The Platelet as a Model for Chemical Genetics
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Molecular and cellular mechanisms of allergic disease
Force as a Facilitator of Integrin Conformational Changes during Leukocyte Arrest on Blood Vessels and Antigen-Presenting Cells  Ronen Alon, Michael L.
A, schematic representation of the “classic” role of uPAR in tumor biology. A, schematic representation of the “classic” role of uPAR in tumor biology.
Edward M. Boyle, Timothy H. Pohlman, Carol J. Cornejo, Edward D
Woo-Yong Lee, Paul Kubes  Journal of Hepatology 
Presentation transcript:

The antithrombotic and antiinflammatory mechanisms of action of aprotinin  R.Clive Landis, PhD, George Asimakopoulos, Mike Poullis, Dorian O. Haskard, Kenneth M. Taylor  The Annals of Thoracic Surgery  Volume 72, Issue 6, Pages 2169-2175 (December 2001) DOI: 10.1016/S0003-4975(01)02821-1

Fig 1 The proteolytic activation mechanism of the thrombin receptor PAR1. Thrombin initially binds to a hirudin-like motif on PAR1 before cleaving the receptor at arginine 41. Cleavage unmasks a “tethered ligand” sequence in the ectodomain, which is now available to dock within the ligand-binding pocket located between extracellular loops 2 and 3 of the transmembrane domain. Cleavage occurs via the serine protease activity of thrombin in conjunction with other “cofactors,” some of which are serine proteases that may themselves be targets of aprotinin. Proteolytic activation of PAR1 is followed by translocation of heterotrimeric G protein signals, Ca2+ fluxing and downstream activation events, such as platelet aggregation and serotonin secretion. (For a good review on protease-activating receptors, see the article by Coughlin [16].) The Annals of Thoracic Surgery 2001 72, 2169-2175DOI: (10.1016/S0003-4975(01)02821-1)

Fig 2 Selective blocking of PAR1-mediated activation of platelets by aprotinin. This schematic summarizes the effect of aprotinin on platelet activation in response to proteolysis-dependent agonists (ie. thrombin and trypsin) versus proteolysis-independent agonists (ie, collagen, ADP or epinephrine). Aprotinin selectively blocks proteolysis-dependent modes of activation mediated via the PAR1 receptor, but not proteolysis-independent modes, which are mediated via the collagen, ADP, or epinephrine receptors (after Poullis and associates [20]). The Annals of Thoracic Surgery 2001 72, 2169-2175DOI: (10.1016/S0003-4975(01)02821-1)

Fig 3 The leukocyte–endothelial cell adhesion cascade. The three main phases of the adhesion cascade are shown: 1. leukocyte rolling, 2. firm adhesion, and 3. extravasation. Also indicated are the points at which the major categories of adhesion molecules and proteases play a role. The initial tethering and rolling phase under hydrodynamic shear flow is mediated by the selectin family of adhesion molecules, E-, P- and L-selectin, which are characterized by rapid on:off rates for their lectin-type ligands. The firm adhesion step is mediated by the integrins, such as Mac-1, LFA-1 and VLA-4, which have evolved as conditional adhesion molecules on leukocytes that require prior activation, usually via a chemokine, before they can mediate adherence to endothelium. Endothelial counterligands for the integrins are members of the immunoglobulin supergene family and include ICAM-1, ICAM-2, and CD31. Chemokines are generated from within the tissues and are transported to the apical side of the blood vessel where they are “presented” on the glycocalyx to rolling leukocytes looking for signs of underlying tissue injury or infection. The extravasation and tissue migration steps involve further contributions from proteases of the elastase and metalloproteinase families, which are secreted at the leading edge of leukocytes, where they digest cell:cell junctions or subendothelial matrix components ahead of the migrating cell. (For a good review of the leukocyte–endothelial cell adhesion cascade, see Frenette and Wagner [46].) The Annals of Thoracic Surgery 2001 72, 2169-2175DOI: (10.1016/S0003-4975(01)02821-1)